462 Intravenous and oral ibandronate reduce the risk of...

462 Intravenous and oral ibandronate reduce the risk of skeletal related events in patients with metastatic bone disease

J.-J. Body, D. Tripathy, M. Pecherstorfer, B. Bergstrom
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
1
Year:
2003
Language:
english
DOI:
10.1016/s1359-6349(03)90494-0
File:
PDF, 156 KB
english, 2003
Conversion to is in progress
Conversion to is failed